Table 2.
Classification | Bcl-xl protein expression | Bcl-xs/l protein expression | ||
---|---|---|---|---|
χ ± S | P value | χ ± S | P value | |
Normal endometrium | 41.00 ± 21.05 | 105.60 ± 33.05 | ||
Simple hyperplasia | 49.00 ± 11.36 | 0.57 | 96.00 ± 50.48 | 0.75 |
Atypical hyperplasia | 49.00 ± 11.36 | 0.56 | 73.00 ± 4.47 | 0.04 |
Endometrial carcinoma | 90.88 ± 48.33 | 0.04 | 54.50 ± 18.49 | 0.00 |
Degree of Pathological Differentiation | ||||
Well-differentiated | 109.29 ± 39.06 | 57.71 ± 22.33 | ||
Moderately-differentiated | 71.50 ± 13.53 | F = 4.65 | 56.50 ± 17.81 | F = 0.32 |
Poorly-differentiated | 56.67 ± 17.21 | P = 0.03 | 46.67 ± 4.04 | P = 0.74 |
Clinical Staging | ||||
Stage I | 85.17 ± 50.83 | 61.17 ± 16.03 | ||
Stage II | 108.00 ± 48.08 | F = 0.30 | 45.50 ± 2.12 | F = 4.02 |
Stage III | 108.00 ± 52.33 | P = 0.74 | 30.50 ± 6.36 | P = 0.04 |
Lymph Node Metastasis | ||||
No | 88.43 ± 49.33 | F = 0.06 | 55.43 ± 21.58 | F = 0.95 |
Yes | 108.00 ± 52.33 | P = 0.61 | 30.00 ± 5.66 | P = 0.02 |
Depth of Myometrial Invasion | ||||
0 | 76.80 ± 18.78 | 65.60 ± 19.92 | ||
≤ 1/2 | 86.00 ± 38.58 | F = 1.13 | 52.25 ± 18.55 | F = 1.34 |
> 1/2 | 127.33 ± 94.99 | P = 0.35 | 46.67 ± 2.52 | P = 0.30 |